Hsa-miR-195-5p Inhibits Autophagy and Gemcitabine Resistance of Lung Adenocarcinoma Cells via E2F7/CEP55-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Hsa-miR-195-5p Inhibits Autophagy and Gemcitabine Resistance of Lung Adenocarcinoma Cells via E2F7/CEP55

Published:2023-01-19 Issue:4 Volume:61 Page:1528-1547
ISSN:0006-2928
Container-title:Biochemical Genetics
language:en
Short-container-title:Biochem Genet

Author:

Fu Linhai,Li Zhupeng,Wu Yuanlin,Zhu Ting,Ma Zhifeng,Dong Lingjun,Ding Jianyi,Zhang Chu,Yu Guangmao

Funder

To investigate the value and mechanism of CEP55 gene as a diagnostic and independent prognostic factor in LUAD

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Molecular Biology,General Medicine,Ecology, Evolution, Behavior and Systematics,Biochemistry

Link

https://link.springer.com/content/pdf/10.1007/s10528-023-10330-y.pdf

Reference45 articles.

1. An Q, Zhou L, Xu N (2018) Long noncoding RNA FOXD2-AS1 accelerates the gemcitabine-resistance of bladder cancer by sponging miR-143. Biomed Pharmacother 103:415–420. https://doi.org/10.1016/j.biopha.2018.03.138

2. Booth LA, Roberts JL, Dent P (2020) The role of cell signaling in the crosstalk between autophagy and apoptosis in the regulation of tumor cell survival in response to sorafenib and neratinib. Semin Cancer Biol 66:129–139. https://doi.org/10.1016/j.semcancer.2019.10.013

3. Bu L, Tian Y, Wen H, Jia W, Yang S (2021) miR-195-5p exerts tumor-suppressive functions in human lung cancer cells through targeting TrxR2. Acta Biochim Biophys Sin 53:189–200. https://doi.org/10.1093/abbs/gmaa159

4. Chen W et al (2021) Downregulation of lncRNA ZFAS1 inhibits the hallmarks of thyroid carcinoma via the regulation of miR3023p on cyclin D1. Mol Med Rep. https://doi.org/10.3892/mmr.2020.11640

5. Chiu HW et al (2016) Combination of the novel histone deacetylase inhibitor YCW1 and radiation induces autophagic cell death through the downregulation of BNIP3 in triple-negative breast cancer cells in vitro and in an orthotopic mouse model. Mol Cancer 15:46. https://doi.org/10.1186/s12943-016-0531-5

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From sequencing to validation: NGS-based exploration of plasma miRNA in papillary thyroid carcinoma;Frontiers in Oncology;2024-08-07

2. Autophagy-driven regulation of cisplatin response in human cancers: Exploring molecular and cell death dynamics;Cancer Letters;2024-04

3. Acquired and intrinsic gemcitabine resistance in pancreatic cancer therapy: Environmental factors, molecular profile and drug/nanotherapeutic approaches;Environmental Research;2024-01

4. Regulatory miRNAs in cancer cell recovery from therapy exposure and its implications as a novel therapeutic strategy for preventing disease recurrence;The Enzymes;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3